INMiND Office
European Institute for Molecular Imaging (EIMI) Waldeyerstr. 15 48149 Münster
Tel.: +49 251 83 49300
Fax: +49 251 83 49313

Metanavigation: 


WELCOME TO INMiND

Imaging of Neuroinflammation in Neurodegenerative Diseases


The goal of INMiND is to identify novel biological targets of neuroinflammation for both diagnostic and therapeutic purposes and to translate this knowledge into clinical application and patient benefit. This aim will be achieved through carrying out collaborative research on molecular mechanisms that link neuroinflammation with neurodegeneration.


Latest News

INMiND consortium well on track to reach its ambitious goals

[2015-02-27] For the third time the INMiND consortium came together to discuss the project’s key developments focussing on dynamics of microglia activation and its contribution to neuronal degeneration and regeneration by molecular imaging technologies in vivo under various paradigms including immunomodulation. more …

Topim 2015 90x90

INMiND consortium again co-organizer of ESMI Winter Conference in the French Alps

[2015-02-09] Like last year INMiND was co-organiser of the ESMI Winter Conference which took place on February 1-6 at the École de Physique in Les Houches, France. This year’s hot meeting topic was ‘Imaging Inflammation’. more …

Antwerpen 90x90

INMiND consortium strongly represented at EMIM2014

[2014-06-07] At the 9th European Molecular Imaging Meeting (EMIM2014) in Antwerp organised by the European Society for Molecular Imaging (ESMI), the INMiND coordinator and past president of the ESMI, Prof Andreas H Jacobs, gave a talk on the overall idea and major aims of the INMiND project in a dedicated EC projects session. more …


RSS-Feed
More News


CONTACT

INMiND Office
Register now for an INMiND training course!
INMiND at a glance!
This collaborative project is funded by the Seventh Framework Programme of the European Union

Imprint | © 2012
INMiND Office
European Institute for Molecular Imaging (EIMI) Waldeyerstr. 15
· 48149 Münster
Tel.: +49 251 83 49300 · Fax: +49 251 83 49313
E-Mail: